Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting

Presentation to highlight therapeutic potential of Athira’s small molecules targeting the neurotrophic HGF system in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s...

Related Keywords

Colorado ,United States ,Washington ,Seattle ,Denver ,American ,Athira Pharma ,Janine Bogris ,Kevin Church ,Instagram ,Securities Exchange ,American Academy Of Neurology ,Athira Pharma Inc ,Linkedin ,Facebook ,Twitter ,Nasdaq ,Exchange Commission ,American Academy ,Targeting Neurotrophic ,Poster Session ,General Neurology ,Chief Scientific Officer ,Scientific Publications ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Markets ,